MedTrace Logo

Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA

NCT00795223 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2009-09-29

No results posted yet for this study

Summary

Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine for single femoral nerve block

Conditions

  • Post Operative Pain
  • Total Knee Replacement

Interventions

DRUG

morphine and bupivacaine

0.3 mg morphine for spinal together with 0.5% bupivacaine for femoral nerve block

DRUG

spinal morphine and marcaine

0.3 mg spinal morphine together with 0.25% bupivacaine for femoral nerve block

DRUG

morphine and bupivacaine

0.2 mg morphine for spinal 0.5% bupivacaine for femoral nerve block

DRUG

morphine and bupivacaine

0.2 mg morphine for spinal together with 0.25% bupivacaine for femoral nerve block

Sponsors & Collaborators

  • Siriraj Hospital

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Thitima Chinachoti, MD · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795223 on ClinicalTrials.gov